Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$29.88 - $37.04 $9,979 - $12,371
-334 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$34.54 - $47.25 $11,501 - $15,734
-333 Reduced 49.93%
334 $13,000
Q2 2021

Jul 27, 2021

BUY
$34.54 - $47.25 $11,501 - $15,734
333 Added 99.7%
667 $38,000
Q1 2021

Apr 27, 2021

SELL
$42.51 - $63.78 $14,155 - $21,238
-333 Reduced 49.93%
334 $15,000
Q4 2020

Feb 01, 2021

BUY
$45.3 - $60.27 $15,084 - $20,069
333 Added 99.7%
667 $38,000
Q3 2020

Nov 03, 2020

BUY
$47.45 - $62.95 $15,848 - $21,025
334 New
334 $15,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $6.41B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Heritage Wealth Advisors Portfolio

Follow Heritage Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Wealth Advisors with notifications on news.